Article Versions Notes

Baldelli E, El Gazzah E, Moran JC, Hodge KA, Manojlovic Z, Bassiouni R, Carpten JD, Ludovini V, Baglivo S, Crinò L, et al. Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas. Genes. 2021; 12(9):1402. https://doi.org/10.3390/genes12091402

Baldelli, Elisa, Emna El Gazzah, John Conor Moran, Kimberley A. Hodge, Zarko Manojlovic, Rania Bassiouni, John D. Carpten, Vienna Ludovini, Sara Baglivo, Lucio Crinò, and et al. 2021. "Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas" Genes 12, no. 9: 1402. https://doi.org/10.3390/genes12091402

Baldelli, E., El Gazzah, E., Moran, J. C., Hodge, K. A., Manojlovic, Z., Bassiouni, R., Carpten, J. D., Ludovini, V., Baglivo, S., Crinò, L., Bianconi, F., Dong, T., Loffredo, J., Petricoin, E. F., & Pierobon, M. (2021). Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas. Genes, 12(9), 1402. https://doi.org/10.3390/genes12091402